Conventional Cartilaginous Tumors

[1]  A. Hirbe,et al.  Non-Conventional Treatments for Conventional Chondrosarcoma , 2020, Cancers.

[2]  T. Ozaki,et al.  What Factors Are Associated with Treatment Outcomes of Japanese Patients with Clear Cell Chondrosarcoma? , 2020, Clinical orthopaedics and related research.

[3]  S. Choe,et al.  Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Jun Dong,et al.  The utility of 18F-FDG PET and PET/CT in the diagnosis and staging of chondrosarcoma: a meta-analysis , 2019, Journal of Orthopaedic Surgery and Research.

[5]  B. Brigman,et al.  Revisiting the Role of Radiation Therapy in Chondrosarcoma: A National Cancer Database Study , 2019, Sarcoma.

[6]  J. Bloem,et al.  Radiologic differentiation of enchondromas, atypical cartilaginous tumors, and high‐grade chondrosarcomas—Improving tumor‐specific treatment: A paradigm in transit? , 2019, Cancer.

[7]  P. Raiss,et al.  Outcome of conservative and surgical treatment of enchondromas and atypical cartilaginous tumors of the long bones: retrospective analysis of 228 patients , 2019, BMC Musculoskeletal Disorders.

[8]  M. Wells,et al.  A 40-Year-Old Male Presenting with Hereditary Multiple Exostosis: Management and Considerations , 2019, Case reports in orthopedics.

[9]  P. Dijkstra,et al.  Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas. , 2018, Surgical oncology.

[10]  D. Campanacci,et al.  Conventional Primary Central Chondrosarcoma of the Pelvis: Prognostic Factors and Outcome of Surgical Treatment in 162 Patients , 2018, The Journal of bone and joint surgery. American volume.

[11]  S. Kliethermes,et al.  Dedifferentiated chondrosarcoma: A survival analysis of 159 cases from the SEER database (2001‐2011) , 2017, Journal of surgical oncology.

[12]  G. Farfalli,et al.  Is Needle Biopsy Clinically Useful in Preoperative Grading of Central Chondrosarcoma of the Pelvis and Long Bones? , 2017, Clinical orthopaedics and related research.

[13]  L. Doyle,et al.  Refinements in Sarcoma Classification in the Current 2013 World Health Organization Classification of Tumours of Soft Tissue and Bone. , 2016, Surgical oncology clinics of North America.

[14]  J. Lubahn,et al.  Enchondroma of the Hand: Evaluation and Management , 2016, The Journal of the American Academy of Orthopaedic Surgeons.

[15]  D. Viola,et al.  Is PET–CT an accurate method for the differential diagnosis between chondroma and chondrosarcoma? , 2016, SpringerPlus.

[16]  D. Biau,et al.  Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study. , 2015, European journal of cancer.

[17]  J. Hardes,et al.  Metastatic Potential of Grade I Chondrosarcoma of Bone: Results of a Multi-institutional Study , 2015, Annals of Surgical Oncology.

[18]  P. Gikas,et al.  How safe is curettage of low-grade cartilaginous neoplasms diagnosed by imaging with or without pre-operative needle biopsy? , 2014, The bone & joint journal.

[19]  B. Alman,et al.  Hedgehog Pathway Inhibition in Chondrosarcoma Using the Smoothened Inhibitor IPI-926 Directly Inhibits Sarcoma Cell Growth , 2014, Molecular Cancer Therapeutics.

[20]  K. Verstraete,et al.  Dynamic contrast-enhanced MR imaging for differentiation between enchondroma and chondrosarcoma , 2013, European Radiology.

[21]  H. Douis,et al.  MRI differentiation of low-grade from high-grade appendicular chondrosarcoma , 2013, European Radiology.

[22]  P. Picci,et al.  Clinical outcome of central conventional chondrosarcoma , 2012, Journal of surgical oncology.

[23]  A. Cleton-Jansen,et al.  Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  S. Sabharwal,et al.  The safety of direct primary excision of low-grade chondral lesions based on radiological diagnosis alone. , 2012, Acta orthopaedica Belgica.

[25]  N. Socci,et al.  Identification of a novel, recurrent HEY1‐NCOA2 fusion in mesenchymal chondrosarcoma based on a genome‐wide screen of exon‐level expression data , 2012, Genes, chromosomes & cancer.

[26]  A. Futreal,et al.  Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2 , 2011, Nature Genetics.

[27]  S. Fehlberg,et al.  Survival and prognostic factors in chondrosarcoma , 2011, Acta orthopaedica.

[28]  J. Wunder,et al.  High‐risk extracranial chondrosarcoma , 2011, Cancer.

[29]  F. Farrokhyar,et al.  A Systematic Review and Meta-analysis of Intralesional Versus Wide Resection for Intramedullary Grade I Chondrosarcoma of the Extremities , 2011, Annals of Surgical Oncology.

[30]  P. Lin,et al.  Secondary Chondrosarcoma , 2010, The Journal of the American Academy of Orthopaedic Surgeons.

[31]  S. Cannon,et al.  An Evaluation of the Diagnostic Accuracy of the Grade of Preoperative Biopsy Compared to Surgical Excision in Chondrosarcoma of the Long Bones , 2010, International journal of surgical oncology.

[32]  F. Bertoni,et al.  Surgical Treatment of Grade I Central Chondrosarcoma , 2010, Clinical orthopaedics and related research.

[33]  Hye Jin Yoo,et al.  Differentiating high-grade from low-grade chondrosarcoma with MR imaging , 2009, European Radiology.

[34]  J. Pitcher,et al.  Extended Intralesional Treatment versus Resection of Low-grade Chondrosarcomas , 2009, Clinical orthopaedics and related research.

[35]  Saskia Le Cessie,et al.  Assessment of Interobserver Variability and Histologic Parameters to Improve Reliability in Classification and Grading of Central Cartilaginous Tumors , 2009, The American journal of surgical pathology.

[36]  H. Gelderblom,et al.  The clinical approach towards chondrosarcoma. , 2008, The oncologist.

[37]  F. Sim,et al.  Does Local Recurrence Impact Survival in Low-grade Chondrosarcoma of the Long Bones? , 2007, Clinical orthopaedics and related research.

[38]  B. Manaster.  Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones. , 2007, The Journal of bone and joint surgery. American volume.

[39]  S. Scully,et al.  An Institutional Review of Clear Cell Chondrosarcoma , 2005, Clinical orthopaedics and related research.

[40]  F. Bertoni,et al.  Surgical treatment and outcome of conventional pelvic chondrosarcoma. , 2005, The Journal of bone and joint surgery. British volume.

[41]  A. Monaco,et al.  Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study. , 2004, The Journal of bone and joint surgery. British volume.

[42]  F. Sim,et al.  Treatment and Outcome of Recurrent Pelvic Chondrosarcoma , 2002, Clinical orthopaedics and related research.

[43]  J. Healey,et al.  Cartilage Tumors: Evaluation and Treatment , 2000, The Journal of the American Academy of Orthopaedic Surgeons.

[44]  J. Bloem,et al.  Cartilaginous tumors: fast contrast-enhanced MR imaging. , 2000, Radiology.

[45]  J. Block,et al.  Multidrug resistance‐1 and p‐glycoprotein in human chondrosarcoma cell lines: Expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance , 1999 .

[46]  P. Hogendoorn,et al.  Chondrosarcoma of the phalanx , 1999, Cancer.

[47]  D J Flemming,et al.  Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[48]  T. Aigner,et al.  Chondrocytic cell differentiation in clear cell chondrosarcoma. , 1996, Human pathology.

[49]  H. Schwartz,et al.  The malignant potential of enchondromatosis. , 1987, The Journal of bone and joint surgery. American volume.

[50]  J. Mirra,et al.  A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathologic analysis of 51 cases. , 1985, Clinical orthopaedics and related research.

[51]  W. Enneking,et al.  A System for the Surgical Staging of Musculoskeletal Sarcoma , 1980, Clinical orthopaedics and related research.

[52]  R. Marcove,et al.  Chondrosarcoma of the pelvis and upper end of the femur. An analysis of factors influencing survival time in one hundred and thirteen cases. , 1972, The Journal of bone and joint surgery. American volume.

[53]  L. Ackerman,et al.  Chondrosarcoma of bone , 1952, Cancer.